Abeona Therapeutics
ABEO
#8122
Rank
NZ$0.45 B
Marketcap
NZ$8.43
Share price
0.00%
Change (1 day)
-17.63%
Change (1 year)

Revenue for Abeona Therapeutics (ABEO)

Revenue in 2025 (TTM): NZ$0.65 Million

According to Abeona Therapeutics 's latest financial reports the company's current revenue (TTM ) is NZ$0.69 Million. In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of NZ$5.53 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Abeona Therapeutics from 1999 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$0.65 M
2024 N/A-100%
2023 NZ$5.53 M148.5%
2022 NZ$2.22 M-49.29%
2021 NZ$4.39 M-68.31%
2020 NZ$13.85 M
2019 N/A-100%
2018 NZ$0.57 M-50.92%
2017 NZ$1.17 M-8.17%
2016 NZ$1.28 M-15.54%
2015 NZ$1.51 M28.71%
2014 NZ$1.18 M-52.49%
2013 NZ$2.48 M-53.58%
2012 NZ$5.35 M126.21%
2011 NZ$2.36 M279.58%
2010 NZ$0.62 M28.65%
2009 NZ$0.48 M-3.35%
2008 NZ$0.5 M
2004 NZ$0.76 M-61.38%
2003 NZ$1.99 M-9.1%
2002 NZ$2.19 M274.52%
2001 NZ$0.58 M
1999 NZ$0.03 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Taro Pharmaceutical
TARO
NZ$1.05 B 152,607.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
NZ$111.19 B 16,058,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA